Seegene Inc

Beyond the current HPV diagnosis

Clinically validated Seegene HPV assays

Complete solution for
HPV screening and genotyping

Anyplex™ II HPV HR and HPV28 Detection are designed to identify 14 and/or 28 different HPV types in a single specimen and fulfill all clinical requirements for the primary cervical cancer screening.

Anyplex™ II HPV HR Detection Anyplex™ II HPV28 Detection

EUROGIN 2021 Virtual Meeting

Seegene Symposium is available on-line

If you are a registrant of EUROGIN 2021 Virtual Meeting, you can join Seegene symposium on the clinical validation result of Seegene’s assays for women’s health including HPV on EUROGIN 2021 virtual congress site.

EUROGIN Virtual Congress Site

Enhancing Vaginal Care through Molecular diagnosis: HPV, STIs, and Vaginitis

Chair: Hélène Péré (HEGP AP-HP, France)

Impact of HPV vaccination - Luxembourg experience
Ardashel Latsuzbaia (LNS, Luxembourg)
Screening for sexually transmitted pathogens
Hilmar Wisplinghoff (Labor Dr. Wisplinghoff, Germany)
Diagnosis of vaginitis: are we doing our best?
Pedro Vieira Baptista (Hospital Lusíadas Porto, Portugal)

Download brochures

Download the brochures for the results of various studies and detailed information of the Seegene HPV assays.

Excellent clinical performance in VALGENT-3 framework

The clinical performance of Anyplex™ II HPV HR Detection showed comparable outcomes with Hybrid Capture 2 HPV DNA test (HC2) and Cobas 4800 HPV test (Cobas) in VALGENT-3 study.

Reference - Ostrbenk et al. (2018) Journal of Clinical Microbiology

 Fulfillment of international guidelines

Anyplex™ II HPV HR Detection fulfills the international consensus validation metrics for HPV DNA tests for cervical cancer screening.

Reference - Hessenlink AT et al. Journal of Clinical Virology (2016) 76:36-39,  Meijer CJLM et al. Int J Cancer (2009)124(3):516~20

100% proficient results in the WHO HPV LabNet study

Anyplex™ II HPV28 Detection had 100% proficient results for HPV type detection from all participants in the WHO HPV LabNet international proficiency study.

Reference - Carina EKlund et al. Journal of Clinical Virology (2018) 101:74-85

Seegene's automation platform

Anyplex™II HPV HR and HPV28 Detection can be applied on Seegene's automation platform, which streamlines and optimizes the workflow of HPV genotyping and screening.